World's Best Scientists 2026 revealed!
Journal of Biopharmaceutical Statistics
H-index 11

Journal of Biopharmaceutical Statistics

1054-3406

Published by: Taylor & Francis

https://www.tandfonline.com/journals/lbps20

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Mathematics 658 11 14 3
Medicine 2475 47 38 9

Additional Metrics

Number of Best Scientists*: 84
Documents by Best Scientists*: 62
Top 100 Ranked Scientists*: 2
SCIMAGO H-index: 58
SCIMAGO SJR: 0.565
Impact Factor: 1.2

Overview

Top Research Topics at Journal of Biopharmaceutical Statistics?

The objective of the journal is to combine knowledge in the areas of Statistics, Econometrics, Clinical trial, Sample size determination and Data mining. Confidence interval, Type I and type II errors, Statistical hypothesis testing, Covariate and Estimator are among the areas of Statistics tackled. The concepts on Econometrics presented in the journal can also apply to other research fields, including Bioequivalence and Missing data.

It holds forums on Clinical trial that merges themes from other disciplines such as Drug development, Medical physics, Randomized controlled trial and Bayesian probability. While work presented in it provided substantial information on Sample size determination, it also covered topics in Research design and Equivalence (measure theory).

  • Statistics (50.83%)
  • Econometrics (24.07%)
  • Clinical trial (22.65%)

What are the most cited papers published in the journal?

  • Agreement Between Methods of Measurement with Multiple Observations Per Individual (1209 citations)
  • ACCOUNTING FOR DROPOUT BIAS USING MIXED-EFFECTS MODELS (292 citations)
  • Adaptive Designs in Clinical Drug Development—An Executive Summary of the PhRMA Working Group (266 citations)

Research areas of the most cited articles at Journal of Biopharmaceutical Statistics:

The journal papers focus on Statistics, Clinical trial, Econometrics, Sample size determination and Data mining. While Econometrics is the focus of the most cited articles, it also provides insights into the studies of Selection (genetic algorithm), Missing data, Estimator and Repeated measures design. The most cited papers focus on Data mining but the discussions also offer insight into other areas such as Bayesian probability and Bayes' theorem.

What topics the last edition of the journal is best known for?

  • Statistics
  • Internal medicine
  • Cancer

The previous edition focused in particular on these issues:

Journal of Biopharmaceutical Statistics primarily focuses on research topics in Statistics, Clinical trial, Sample size determination, Covariate and Machine learning. The research on Statistics discussed in Journal of Biopharmaceutical Statistics draws on the closely related field of Variance (accounting). Clinical trial research presented in Journal of Biopharmaceutical Statistics encompasses a variety of subjects, including Physical therapy, Categorical variable, Data science and Hysteresis (economics).

Sample size determination research featured in the journal incorporates concerns from various other topics such as Test (assessment), Interim analysis, Duration (project management), Binary number and Protocol (science). The studies on Covariate discussed can also contribute to research in the domains of Cut off point, Parametric statistics, Linear regression and Bayesian inference. It facilitates discussions on Machine learning that incorporate concepts from other fields like Statistical inference and Prior probability, Bayesian probability, Artificial intelligence.

The most cited articles from the last journal are:

  • Construction of a survival tree for dependent censoring. (3 citations)
  • Incorporating propensity scores for evidence synthesis under bayesian framework: review and recommendations for clinical studies. (2 citations)
  • A year in review: artificial intelligence permeates into mainstream statistics in pharmaceutical product development at a laggard pace. (2 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Journal of Biopharmaceutical Statistics (based on the number of publications) are:

  • Shein-Chung Chow (90 papers) absent at the last edition,
  • Yi Tsong (67 papers) absent at the last edition,
  • Gary G. Koch (42 papers) published 1 paper at the last edition the same number as at the previous edition,
  • Geert Molenberghs (35 papers) absent at the last edition,
  • Jen-pei Liu (31 papers) absent at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Journal of Biopharmaceutical Statistics (based on the number of publications) are:

  • Center for Drug Evaluation and Research (103 papers) absent at the last edition,
  • Duke University (99 papers) published 1 paper at the last edition, 3 less than at the previous edition,
  • University of North Carolina at Chapel Hill (94 papers) published 1 paper at the last edition, 10 less than at the previous edition,
  • Novartis (90 papers) absent at the last edition,
  • Merck & Co. (81 papers) published 1 paper at the last edition, 1 less than at the previous edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 7.27% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 23.53% were posted by at least one author from the top 10 institutions publishing in the journal. Another 13.73% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 15.69% of all publications and 47.06% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Top Publications

  • Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data

    Wei Chen Chen;Chenguang Wang;Heng Li;Nelson Lu

    (2020)
    41 Citations
  • Propensity score-integrated composite likelihood approach for incorporating real-world evidence in single-arm clinical studies.

    Chenguang Wang;Nelson Lu;Wei Chen Chen;Heng Li

    (2020)
    33 Citations
  • A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome

    Ian R. White;Royes Joseph;Nicky Best

    (2020)
    23 Citations
  • Bayesian Semi-parametric Design (BSD) for adaptive dose-finding with multiple strata.

    Mo Li;Rachael Liu;Jianchang Lin;Veronica Bunn

    (2020)
    22 Citations
  • Evaluating bias control strategies in observational studies using frequentist model averaging

    (2022)
    18 Citations
  • Matching design for augmenting the control arm of a randomized controlled trial using real-world data

    (2022)
    17 Citations
  • Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials.

    Samvel B Gasparyan;Elaine K Kowalewski;Folke Folkvaljon;Olof Bengtsson

    (2021)
    16 Citations
  • The precision interventions for severe and/or exacerbation-prone asthma (PrecISE) adaptive platform trial: statistical considerations.

    Anastasia Ivanova;Elliot Israel;Lisa M. LaVange;Michael C. Peters

    (2020)
    13 Citations
  • Propensity score-integrated power prior approach for augmenting the control arm of a randomized controlled trial by incorporating multiple external data sources

    Nelson Lu;Chenguang Wang;Wei-Chen Chen;Heng Li

    (2021)
    11 Citations

Related Online Degrees & Career Pathways

For those interested in expanding their healthcare knowledge beyond traditional medical studies, several online degree options offer flexible and accelerated pathways. Students seeking to enhance their expertise in nutrition can explore an accelerated nutrition degree online, which provides a convenient route to becoming licensed dietitians or nutritionists.

Nurses aiming to advance their careers often consider an easiest rn to bsn program, offering streamlined coursework to obtain a Bachelor of Science in Nursing while balancing work and life commitments.

For leadership roles, an online masters healthcare management degree equips professionals with essential administrative and management skills, preparing them to navigate the complexities of healthcare systems effectively.

Those interested in mental health nursing can accelerate their credentials through accelerated msn psychiatric np programs, gaining specialized expertise to become psychiatric nurse practitioners and address critical mental health needs.

Best Scientists Contributing to This Journal